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The prevalence of allergic diseases has rapidly
increased in developed countries throughout
the past several decades (Beasley et al. 2003).
Changes in environmental factors such as
allergen load, infectious disease proﬁle, vacci-
nation, and the presence of environmental
adjuvants, rather than genetic factors, are
likely to be considered as the cause of this
increase (Etzel 2003; Strachan 2000). We
have previously reported that diesel exhaust
particles—environmental adjuvants that con-
tain a vast number of organic chemicals—
enhance murine models of allergic asthma
(Ichinose et al. 2004; Miyabara et al. 1998;
Sadakane et al. 2002; Takano et al. 1997). A
recent epidemiologic study has revealed the
positive association between allergic asthma in
children and phthalate esters in house dust
(Bornehag et al. 2004). Among phthalate
esters, di-(2-ethylhexyl) phthalate (DEHP)
has been widely used [1.8 million metric
tons/year (Cadogan and Howick 1996)] in
polyvinyl chloride products, including vinyl
ﬂooring, wall coverings, food containers, and
infant toys, and has become ubiquitous in
developed countries since the end of World
War II. Larsen et al. (2001) suggested that
DEHP displays an adjuvant effect on allergen-
related immunoglobulin production. In con-
trast, house dust mite allergens—major
allergens in humans—closely relate to (Schafer
et al. 1999) or enhance (Sanda et al. 1992)
atopic dermatitis. However, the association
between DEHP and atopic dermatitis has
never been elucidated. In the present study we
investigated the effects of DEHP on atopic
dermatitis-like skin lesions induced by mite
allergen in NC/Nga mice, an animal model
described previously by Sasakawa et al. (2001).
Materials and Methods
Animals. Seven-week-old SPF NC/Nga male
mice (22–25 g body weight) were purchased
from Charles River Japan (Osaka, Japan) and
maintained in conventional conditions for
1 week. They were fed a commercial diet
(CE-2; Japan Clea Co., Tokyo, Japan) and
water ad libitum. Mice were housed in an ani-
mal facility that was maintained at 22–26°C
with 40–69% humidity and a 12 hr/12 hr
light/dark cycle. The study adhered to the
U.S. National Institutes of Health guidelines
for the use of experimental animals (Institute
of Laboratory Animal Resources 1996). The
mice were handled according to the National
Institute for Environmental Studies animal
guidelines. Animals were treated humanely
and with regard for alleviation of suffering.
Study protocol. Mice were divided into
seven experimental groups. One group received
no treatment (nontreated). In the other groups,
mice were treated with 10 µL saline or 5 µg
mite allergen extract [Dermatophagoides
pteronyssinus (Dp); Cosmo Bio LSL, Tokyo,
Japan] dissolved in saline; mice were injected
intradermally on the ventral side of their right
ears on days 0, 2, 4, 7, 9, 11, 14, and 16
under anesthesia with 4% halothane (Takeda
Pharmaceutical Company, Ltd., Osaka,
Japan). In the presence of allergen, DEHP at a
dose of 0, 0.8, 4, 20, or 100 µg dissolved in
0.1 mL of olive oil (vehicle) was administered
by intraperitoneal injection on days –4, 3, 10,
and 17. Twenty-four hours after each intra-
dermal injection, we measured ear thickness
using a gauge (Ozaki Mfg, Osaka, Japan) and
evaluated clinical scores by skin dryness, erup-
tion, edema, and wound graded from 0 to 3
(no symptoms, 0; mild, 1; moderate, 2; and
severe, 3). The clinical scores were estimated
as the sum of these values.
Histologic evaluation. Right ears of mice
were removed 48 hr after the last injection of
Dp (day 18) and were fixed in 10% neutral
phosphate-buffered formalin (pH 7.2) and
embedded in parafﬁn. Sections of 3 µm were
routinely stained with hematoxylin and eosin
(H&E) or with toluidine blue (pH 4.0).
Histologic analyses were performed using an
AX80 microscope (Olympus, Tokyo, Japan).
We measured the length of the cartilages in
each specimen and counted the numbers of
eosinophils and mast cells in each sample
using a video micrometer (VM-30; Olympus).
The inﬁltration of eosinophils and mast cells
were morphometrically evaluated as the num-
ber of cells per millimeter of the cartilages in a
blind fashion. We also evaluated the degranu-
lation of mast cells as not degranulated (0%),
mildly degranulated (0–50%), and severely
degranulated (> 50%).
ELISA. Right ears of mice were removed
48 hr after the last injection of Dp (day 18)
and were homogenized and centrifuged as
previously described (Takano et al. 1997). We
conducted enzyme-linked immunosorbent
assays (ELISAs) for macrophage inﬂammatory
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Di-(2-ethylhexyl) phthalate (DEHP) has been widely used in polyvinyl chloride products and has
become ubiquitous in the developed countries. DEHP reportedly displays an adjuvant effect on
immunoglobulin production. However, it has not been elucidated whether DEHP is associated with
the aggravation of atopic dermatitis. We investigated the effects of DEHP on atopic dermatitis-like
skin lesions induced by mite allergen in NC/Nga mice. NC/Nga male mice were injected intra-
dermally with mite allergen on their right ears. In the presence of allergen, DEHP (0, 0.8, 4, 20, or
100 µg) was administered by intraperitoneal injection. We evaluated clinical scores, ear thickening,
histologic findings, and the protein expression of chemokines. Exposure to DEHP at a dose of
0.8–20 µg caused deterioration of atopic dermatitis-like skin lesions related to mite allergen; this was
evident from macroscopic and microscopic examinations. Furthermore, these changes were consis-
tent with the protein expression of proinﬂammatory molecules such as macrophage inﬂammatory
protein-1α (MIP-1α) and eotaxin in the ear tissue in overall trend. In contrast, 100 µg DEHP did
not show the enhancing effects. These results indicate that DEHP enhances atopic dermatitis-like
skin lesions at hundred-fold lower levels than the no observed adverse effect level determined on
histologic changes in the liver of rodents. DEHP could be at least partly responsible for the recent
increase in atopic dermatitis. Key words: atopic dermatitis, chemokines, di-(2-ethylhexyl) phthalate,
eosinophils, mast cells. Environ Health Perspect 114:1266–1269 (2006). doi:10.1289/ehp.8985
available via http://dx.doi.org/ [Online 15 May 2006]protein-1α (MIP-1α) (R&D Systems,
Minneapolis, MN, USA) and eotaxin (R&D
Systems) in the ear tissue supernatants accord-
ing to the manufacturer’s instructions. The
detection limits of MIP-1α and eotaxin were
1.5 pg/mL and 3 pg/mL, respectively.
Statistical analysis. Data are reported as
mean ± SE. Differences among groups were
determined using Dunnett’s multiple compari-
son test. A p-value < 0.05 was considered to be
significant (StatView, version 5.0; Abacus
Concepts Inc., Berkeley, CA, USA).
Results
DEHP enhances symptoms of atopic dermati-
tis-like skin lesions. To evaluate the effects of
DEHP on atopic dermatitis-like skin lesions
induced by Dp, we examined clinical scores
and ear thickening. Treatment with Dp signiﬁ-
cantly enhanced clinical scores (p < 0.05:
Figure 1A), including dryness, eruption,
wound, edema, and ear thickening (p < 0.05;
see Supplemental Material available online at
http://www.ehponline.org/docs/2006/8985/
suppl.pdf) compared with no treatment or
saline from day 5. After day 12, exposure to
DEHP at 0.8–20 µg dose-dependently
increased clinical scores and ear thickening
compared with vehicle exposure in the presence
of allergen. The symptoms were most promi-
nent on the treatment with DEHP at 20 µg
(p < 0.01 vs. vehicle treatment). In particular,
combined exposure to 20 µg DEHP and aller-
gen caused marked wound (Figure 1B) com-
pared with exposure to vehicle and allergen
(Figure 1C). We observed no change in the
nontreated group (Figure 1D) or the saline
group (data not shown). On the other hand,
100 µg DEHP did not show the enhancing
effects (Figure 1A).
DEHP aggravates histologic changes in
the skin related to Dp. Histologic examina-
tion with H&E staining showed that expo-
sure to 0.8–20 µg DEHP dose-dependently
enhanced the infiltration of eosinophils into
the skin lesion in the presence of allergen
(Figure 2A; p < 0.01 for 4 or 20 µg DEHP
vs. vehicle). In overall trend, these changes
were paralleled by the severity of mast cell
degranulation (Figure 2E). Treatment with
20 µg DEHP (Figure 2D,H) caused more
prominent histologic changes than that with
vehicle (Figure 2C,G) in the presence of
allergen. No pathologic alterations were
found in the nontreated group (Figure 2B,F)
or saline treatment (data not shown). In con-
trast, 100 µg DEHP did not show the
enhancing effects (Figure 2A,E). 
DEHP modulates the protein expression
of chemokines in the skin related to Dp.
Treatment with Dp increased the expression of
MIP-1α (Figure 3A) and eotaxin (Figure 3B)
compared with nontreated or saline treated
groups (p < 0.05 for MIP-1α; not signiﬁcant
for eotaxin). In the presence of allergen, expo-
sure to 4 or 20 µg DEHP increased the expres-
sion of these chemokines compared with no
treatment (p < 0.01 for MIP-1α after treat-
ment with 4 or 20 µg DEHP; p < 0.01 for
eotaxin after treatment with 4 µg DEHP;
p < 0.05 for eotaxin after treatment with 20 µg
DEHP). Furthermore, combined exposure to
allergen and DEHP enhanced the protein
expression of eotaxin compared with exposure
to allergen and vehicle (p < 0.01 for 4 µg
DEHP; not signiﬁcant for 20 µg DEHP).
Discussion
In the present study we have shown that
exposure to DEHP at a dose of 0.8–20 µg
caused deterioration of atopic dermatitis-like
skin lesions related to mite allergen (Dp) in
NC/Nga mice, which is evidenced by macro-
scopic and microscopic examinations.
However, in animals treated with 100 µg
DEHP, we did not observe signiﬁcant effects.
Furthermore, these enhancing effects are paral-
leled by the expression of proinflammatory
molecules such as eotaxin and MIP-1α in ear
tissue in overall trend.
DEHP has been widely used in polyvinyl
chloride and other plastics, including building
products, clothing, food packing, children’s
products, and media devices. Thus, the general
population can be exposed to DEHP in food,
water, and air via ingestion or inhalation.
Jaakkola et al. (1999) suggested that DEHP is
associated with the development of asthma in
children. In addition, DEHP has been shown
to possess adjuvant activity for allergen-related
IgG1 response in mice (Larsen et al. 2001).
Several reports have shown that DEHP in
headphones (Walker et al. 2000) and in a
polyvinyl chloride grip on cotton gloves
(Sugiura et al. 2000, 2002) can induce cases of
contact urticaria syndrome. However, the asso-
ciation between DEHP and atopic dermatitis
has never been elucidated.
In the present study, DEHP caused deteri-
oration of skin lesions and chemokine expres-
sion related to Dp in atopic subjects (NC/Nga
mice) at doses about 1,000-fold lower than the
no observed adverse effect level that was
determined on the basis of histologic changes
in the liver of rodents (19 mg/kg/day)
(Carpenter et al. 1953). Furthermore, we also
evaluated the effects of DEHP on an atopic
dermatitis model using a different strain,
BALB/c mice; the results on BALB/c mice
paralleled those on NC/Nga mice in overall
trend (data not shown). The active doses used
in our study are comparable to the recently
calculated daily intake, the reference dose of
the U.S. Environmental Protection Agency
[20 µg/kg/day (U.S. EPA 2006)], and the tol-
erable daily intake value settled by the
European Union Scientific Committee for
Toxicity [50 µg/kg/day (European Union
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Figure 1. Exposure to DEHP exacerbates atopic dermatitis-like skin lesions induced by Dp on ears.
(A) Clinical scores of the ears 24 hr after each injection (differences among groups were determined using
Dunnett’s multiple comparison test; data are the mean ± SE of 16 animals per group). (B–D) Macroscopic
features 48 hr after the last injection of Dp: (B) Dp + 20 µg DEHP, (C) Dp + vehicle, and (D) nontreated.
*p < 0.05, Dp-treated groups vs. nontreated group and saline + vehicle group. **p < 0.01, Dp treated groups vs. nontreated
group and saline + vehicle group. #p < 0.05, Dp + 4 µg DEHP group vs. Dp + vehicle group. ##p < 0.01, Dp + 20 µg DEHP
group vs. Dp + vehicle group.
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BScientific Committee for Toxicity 2002)] in
humans. These reports and our results suggest
that ambient exposure to DEHP is a possible
contributor to the recent increase in the inci-
dence of atopic dermatitis.
The present study showed that exposure to
0.8–20 µg DEHP caused deterioration of
atopic dermatitis-like skin lesions related to
Dp; however, exposure to 100 µg DEHP did
not show the enhancing effects. The similar
results (inverted U-shaped dose response) have
been typically shown with the effects of
endocrine-disrupting chemicals. Octylphenol
and 4-n-nonylphenol are among the most
important alkylphenolic compounds widely
used in industry and appear to possess intrinsic
estrogenic activity (White et al. 1994).
Exposure to these environmental chemicals has
reportedly exhibited an inverted U-shaped dose
response on the number of unshelled embryos
of snails (Duft et al. 2003). In addition,
bisphenol A, an environmental endocrine dis-
ruptor, has dose-dependently increased the
mRNA levels for aryl hydrocarbon receptor in
mouse gonads at a dose of 0.02–200 µg/kg/day
but decreased them at higher-doses (Nishizawa
et al. 2005). DEHP has also been reported as
an endocrine-disrupting chemical in the
United States and Europe (Dalgaard et al.
2000; Tandon et al. 1991). Our results might
indicate an association between the exposure to
endocrine-disrupting chemicals and the aggra-
vation of allergic responses.
Inﬁltration of inﬂammatory cells into tis-
sues is regulated by chemokines. Eotaxin is an
important contributor to eosinophil recruit-
ment in atopic dermatitis. The levels of eotaxin
are signiﬁcantly higher in patients with atopic
dermatitis than in healthy people (Jahnz-Rozyk
et al. 2005). Gene expression for eotaxin is up-
regulated in ovalbumin-sensitized skin sites
(Spergel et al. 1999). In contrast, MIP-1α has
been chemotactic for neutrophils, macro-
phages, T cells, and B cells, affecting their acti-
vation. Spontaneous production of MIP-1α is
augmented in atopic dermatitis patients
(Kaburagi et al. 2001). An increased transcrip-
tion level for MIP-1α has been associated with
atopic dermatitis (Xin et al. 2001). In the pre-
sent study, exposure to 4 or 20 µg DEHP in
the presence of allergen increased the expres-
sion of these chemokines compared with vehi-
cle combined with allergen. The results suggest
that the enhancement of the expression of
these chemokines by DEHP might, at least
partially, play an important role in that of
atopic dermatitis related to Dp. However,
results on the protein expression of these
chemokines 48 hr after the last allergen instilla-
tion were slightly different from those on the
clinical scores 24 hr after the instillation. The
expression of these molecules might be
enhanced at the earlier time points. We plan to
investigate the time course of the protein
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Figure 2. Histologic changes in the ear 48 hr after the last injection of Dp. The inﬁltration of eosinophils (A)
and mast cells (E) was morphometrically evaluated as the number of cells per millimeter of cartilage, and
the degranulation of mast cells was evaluated as nondegranulated (0%), mildly degranulated (0–50%), and
severely degranulated (> 50%). Differences among groups were determined using Dunnett’s multiple com-
parison test; data shown are the mean ± SE of four animals per group. (B–D, F–H). Photomicrographs (400×
magnification) of ear tissue from the nontreated group (B, F), Dp + vehicle group (C, G), and Dp + 20 µg DEHP
group (D, H) are shown with H&E staining (B–D) or toluidine blue staining (F–H).
*p < 0.05 vs. nontreated group and saline + vehicle group. **p < 0.01 vs. nontreated group and saline + vehicle group.
##p < 0.01 vs. Dp + vehicle group.
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Figure 3. Effects of DEHP on the protein expression of chemokines MIP-1α (A) and eotaxin (B) in ear
homogenates 48 hr after the last injection of Dp as determined by ELISA. Differences among groups were
determined using Dunnett’s multiple comparison test; data shown are the mean ± SE of eight animals
per group. 
*p < 0.05 vs. nontreated group and saline + vehicle group. **p < 0.01 vs. nontreated group and saline + vehicle group.
#p < 0.05 vs. nontreated group. ##p < 0.01 vs. Dp + vehicle group.
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expression of these molecules in the next stage
of our research.
In conclusion, DEHP, which is widely
used in plasticized products and ubiquitous in
the developed world, can be responsible for
the recent increase in atopic dermatitis. The
enhancing effects may be mediated through
the enhanced expression of chemokines.
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